Sandoz will boost delivery tech portfolio with Oriel buy
Sandoz will buy generics firm Oriel Therapeutics, adding the US company’s FreePath delivery system and Solis multi-dose dry powder inhaler to its respiratory drug technology portfolio.
Archives for April 19, 2010
Appointments at Baxter, Dendreon, Roche, Somaxon and Silence Therapeutics – People on the move
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Baxter, Dendreon, Roche, Somaxon and Silence Therapeutics.
Codexis plans $103m IPO this week
Biocatalysis specialist Codexis aims to raise $103m in another initial public offering (IPO) on the Nasdaq Global Market.
PRA sets up in New Zealand
PRA has expanded into New Zealand, complementing its Asia-Pacific network and establishing a point of contact for pharmas interested in benefiting from the county’s high recruitment rates.
Collaboration to give legal, tech advice on CRO, CMO deals
MLawGroup and WS Partners are collaborating to offer pharma and biotech advisory services, including help in preparing and negotiating agreements with CROs and CMOs.
CRL: China site gets GLP cert; new strain supply service launched
Charles River Laboratories’ (CRL) Shanghai preclinical test facility GLP certified by Belgian authorities under the OECD’s mutual acceptance of data framework.
Elan mulls hiving-off drug delivery business again
Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT).